# A Study in Healthy Volunteers and Patients With Mild Asthma to Investigate the Safety, Anti-inflammatory Effect of Inhaled AZD0449

> **NCT03766399** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 131 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** AZD0449
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03766399
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-30
- **Primary completion:** 2021-06-24
- **Final completion:** 2021-06-24
- **Target enrollment:** 131 (ACTUAL)
- **Last updated:** 2024-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03766399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03766399, "A Study in Healthy Volunteers and Patients With Mild Asthma to Investigate the Safety, Anti-inflammatory Effect of Inhaled AZD0449". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT03766399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*